MedTrace Logo

Mechanical Vibration on Children With Cerebral Palsy

NCT05593406 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2023-02-17

No results posted yet for this study

Summary

The purpose of this study was to assess the effect of mechanical vibration on spasticity and balance in children with cerebral palsy. The participants of the clinical study are 13 children with CP and age 4-17 years, with a diagnosis of spastic hemiplegic cerebral palsy. More specifically, the participants were randomly divided into a control group and an intervention group, with the first group continuing conventional physical therapy, while the experimental group outside the physical therapy program did also receive mechanical vibration using a hybervibe G10 vibration platform (lasting 15 minutes). The intervention lasted 8 weeks and participants were assessed before the start of the intervention (T1), 1 month after the first assessment (T2) and rechecked 1 month (T3) after the completion of the program using valid and reliable tools.

Conditions

  • Cerebral Palsy
  • Spastic Hemiplegic Cerebral Palsy

Interventions

DEVICE

Vibration Group

Whole body vibration for 15 minutes in squat and lunge position.

OTHER

Control Group

NDT treatment 2 sessions per week

Sponsors & Collaborators

  • Thomas Besios

    collaborator UNKNOWN

  • Georgios Paras

    collaborator UNKNOWN

  • Konstantinos Chandolias

    collaborator UNKNOWN

  • University of Thessaly

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-30
Primary Completion
2022-12-30
Completion
2023-01-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05593406 on ClinicalTrials.gov